Skip to main content
. 2017 Oct 25;9(10):5617–5622. doi: 10.19082/5617

Table 1.

Gender and age distribution of patients treated with gabapentin and topiramate

Drug Male; n (%) Female; n (%) Age (Year)
Gabapentin 10 (66.7%) 5 (33.3%) 61.86±10.24
Topiramate 8 (53.3%) 7 (46.7%) 65.33±10.53
Total 18 (60%) 12 (40%) 63.6±10.36